Repro Med Systems/KRMD

$2.11

2.92%
-
1D1W1MYTD1YMAX

About Repro Med Systems

KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. It is focused on home and specialty infusion solutions. The Company’s focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.

Ticker

KRMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Linda Tharby

Employees

85

Headquarters

Mahwah, United States

KRMD Metrics

BasicAdvanced
$93.62M
Market cap
-
P/E ratio
-$0.18
EPS
0.51
Beta
-
Dividend rate

What the Analysts think about KRMD

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 5 analysts.
75.36% upside
High $5.00
Low $2.50
$2.11
Current price
$3.70
Average price target

KRMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-18.57% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$7M
1.45%
Net income
$-1.3M
-45.83%
Profit margin
-18.57%
-46.61%

KRMD Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 40%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.04
-$0.05
-$0.05
-$0.03
-
Expected
-$0.06
-$0.05
-$0.06
-$0.05
-$0.04
Surprise
-29.41%
0%
-11.77%
-40%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Repro Med Systems stock

Buy or sell Repro Med Systems stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing